ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis

Michinori Matsuo1

  • 1Department of Food and Nutrition, Faculty of Home Economics, Kyoto Women's University, 35 Imakumanokitahiyoshicyo, Kyoto 605-8501, Japan.

Insights

Targeting ATP-binding cassette proteins A1 (ABCA1) and G1 (ABCG1) can prevent atherosclerosis. Enhancing their cholesterol efflux and anti-inflammatory activities offers a therapeutic strategy for cardiovascular and neurodegenerative diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Atherosclerosis, a major global cardiovascular disease risk factor, stems from cellular cholesterol accumulation.
  • ATP-binding cassette transporters A1 (ABCA1) and G1 (ABCG1) are crucial for reverse cholesterol transport and high-density lipoprotein formation.
  • Dysregulation of ABCA1 and ABCG1 contributes to atherosclerosis progression and associated inflammatory processes.

Purpose of the Study:

  • To review the regulatory mechanisms of ABCA1 and ABCG1.
  • To highlight the therapeutic potential of modulating ABCA1 and ABCG1 for atherosclerosis prevention.
  • To explore the role of ABCA1 and ABCG1 in preventing other conditions like Alzheimer's disease.

Main Methods:

  • Literature review of studies on ABCA1 and ABCG1 function and regulation.
  • Analysis of transcriptional, post-transcriptional, and post-translational control mechanisms.
  • Examination of the impact of ABCA1 and ABCG1 on cholesterol efflux and inflammation.

Main Results:

  • ABCA1 and ABCG1 expression and activity are tightly regulated at multiple levels.
  • Enhanced ABCA1 and ABCG1 function effectively reduce cellular cholesterol and suppress macrophage inflammation.
  • ABCA1 and ABCG1 also play a role in preventing amyloid-beta accumulation, suggesting broader therapeutic applications.

Conclusions:

  • ABCA1 and ABCG1 are promising therapeutic targets for atherosclerosis.
  • Modulating the expression, degradation, and localization of ABCA1 and ABCG1 can prevent cholesterol buildup and inflammation.
  • Targeting ABCA1 and ABCG1 pathways may offer novel strategies for treating cardiovascular and neurodegenerative diseases.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
59
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
2.9K
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
5.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
188
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
151
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
252